Last10K.com

American Bio Medica Corp (ABMC) SEC Filing 10-K Annual report for the fiscal year ending Tuesday, December 31, 2013

American Bio Medica Corp

CIK: 896747 Ticker: ABMC
Document And Entity Information (USD $)
12 Months Ended
Dec. 31, 2013
Mar. 28, 2014
Jun. 28, 2013
Document Information [Line Items]      
Entity Registrant Name AMERICAN BIO MEDICA CORP    
Entity Central Index Key 0000896747    
Current Fiscal Year End Date --12-31    
Entity Filer Category Smaller Reporting Company    
Trading Symbol ABMC    
Entity Common Stock, Shares Outstanding   23,168,155  
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2013    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2013    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Public Float     $ 2,762,000

View differences made from one year to another to evaluate American Bio Medica Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Bio Medica Corp.

Continue

Assess how American Bio Medica Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Bio Medica Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Balance Sheets
Balance Sheets (parenthetical)
Statements Of Cash Flows
Statements Of Changes In Stockholders’ Equity
Statements Of Operations
Accrued Expenses And Other Current Liabilities
Accrued Expenses And Other Current Liabilities (details)
Accrued Expenses And Other Current Liabilities (tables)
Commitments, Contingencies And Other Matters
Commitments, Contingencies And Other Matters (details Textual)
Commitments, Contingencies And Other Matters (details)
Commitments, Contingencies And Other Matters (tables)
Income Taxes
Income Taxes (details 1)
Income Taxes (details Textual)
Income Taxes (details)
Income Taxes (tables)
Inventory
Inventory (details)
Inventory (tables)
Lines Of Credit
Lines Of Credit (details Textual)
Long-term Debt
Long-term Debt (details 1)
Long-term Debt (details Textual)
Long-term Debt (details)
Long-term Debt (tables)
Other Income / Expense
Other Income / Expense (details Textual)
Property, Plant And Equipment
Property, Plant And Equipment (details Textual)
Property, Plant And Equipment (details)
Property, Plant And Equipment (tables)
Related Party Disclosures
Related Party Disclosures (details Textual)
Segment And Geographic Information
Segment And Geographic Information (details)
Segment And Geographic Information (tables)
Stockholders' Equity
Stockholders' Equity (details 1)
Stockholders' Equity (details Textual)
Stockholders' Equity (details)
Stockholders' Equity (tables)
Subsequent Events
Subsequent Events (details Textual)
The Company And Its Significant Accounting Policies
The Company And Its Significant Accounting Policies (details Textual)
The Company And Its Significant Accounting Policies (details)
The Company And Its Significant Accounting Policies (policies)
The Company And Its Significant Accounting Policies (tables)

Material Contracts, Statements, Certifications & more

American Bio Medica Corp provided additional information to their SEC Filing as exhibits

Ticker: ABMC
CIK: 896747
Form Type: 10-K Annual Report
Accession Number: 0001144204-14-019165
Submitted to the SEC: Mon Mar 31 2014 12:38:16 PM EST
Accepted by the SEC: Mon Mar 31 2014
Period: Tuesday, December 31, 2013
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/abmc/0001144204-14-019165.htm